SLC2A1 and neoplasm: Here, TP-PEG-SS, Rg3 and lecithin (PC) were employed in the preparation of nanovesicles (Rg3/TP-PEG-SS NVs, i.e. NVs), which didn't contain cholesterol and could specifically target tumor sites via the mitochondrial pathway [7] and Glut-1 pathway.